Helix BioPharma Appoints New Board Member and Corporate Secretary, Advances Nasdaq Uplisting Strategy
Helix BioPharma strengthens its board and governance with seasoned capital markets and corporate secretarial expertise as it prepares for a Nasdaq listing under the MJDS framework.
